Event Details
January 01, 2010
Description
Patient number 45 enrolled in the everolimus study at Sloan-Kettering.
Participants (1)
| Name | Type | Mentions | |
|---|---|---|---|
| Patient number 45 | person | 4 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_015496.jpg
A magazine article page (p. 36) titled 'An Unlikely Cure Signals New Hope for Cancer' by Kat McGowan. It details a case study at Memorial Sloan-Kettering where a 73-year-old bladder cancer patient ('Patient 45') had a miraculous recovery using the drug everolimus in 2010. The article highlights Dr. David Solit's work in sequencing the patient's genome to identify the mutations responsible for the cure. The document includes a Bates stamp 'HOUSE_OVERSIGHT_015496', indicating it is part of a congressional investigation file.
Related Events
Events with shared participants
Patient number 45's cancer was confirmed gone.
2010-04-01 • Sloan-Kettering
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event